- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Linagliptin/metformin
Total 2677 results
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Evidem Consultores SLBoehringer Ingelheim; Merck Serono International SA; European CommissionUnknown
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Canada, Croatia, Estonia, France, Germany, India, Lithuania, Mexico, Netherlands, Romania, Russian Federation, Sweden, Tunisia, Ukraine
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioUnknownInsulin Resistance | Prediabetic StateMexico
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Brigham and Women's HospitalPatient-Centered Outcomes Research Institute; McGill University; VA Boston Healthcare...Active, not recruitingType2 Diabetes | Renal Disease | Cardiovascular EventsUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimCompleted
-
Merck Sharp & Dohme LLCCompleted
-
GC Biopharma CorpRecruitingHealthy VolunteersKorea, Republic of
-
GC Biopharma CorpRecruitingHealthy VolunteersKorea, Republic of
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 DiabetesUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Israel, Malaysia, Mexico, Philippines, Puerto Rico, Russian Federation, Sri Lanka, Thailand, Ukraine
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Germany
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioCompletedInsulin Resistance | Prediabetic State | Impaired Glucose ToleranceMexico
-
EMSNot yet recruitingType 2 Diabetes Mellitus
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2China, Malaysia, Philippines, Vietnam
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Shahid Beheshti University of Medical SciencesRecruitingPolycystic Ovary Syndrome | Infertility | ARTIran, Islamic Republic of
-
Merck Sharp & Dohme LLCCompleted
-
Bio-innova Co., LtdNot yet recruiting
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Dong Wha Pharmaceutical Co. Ltd.CompletedHealthy SubjectsKorea, Republic of
-
Dong Wha Pharmaceutical Co. Ltd.CompletedHealthy SubjectsKorea, Republic of
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioCompletedInsulin Resistance | Prediabetic StateMexico
-
The Affiliated Hospital of Qingdao UniversityCompleted
-
Genuine Research Center, EgyptEva PharmaCompleted
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Universidad de GuanajuatoHospital Regional de Alta Especialidad del BajioUnknownInsulin Resistance | Prediabetic StateMexico
-
Boehringer IngelheimEli Lilly and CompanyCompleted
-
Boehringer IngelheimCompleted
-
LG Life SciencesCompletedType 2 Diabetes MellitusKorea, Republic of
-
University of PisaMerck Sharp & Dohme LLCCompleted
-
Services Hospital, LahoreCompletedDiabetes, Type 2Pakistan
-
Chong Kun Dang PharmaceuticalCompletedType 2 Diabetes MellitusKorea, Republic of
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus (T2DM)